A Single-Arm Study Assessing the Safety and Efficacy of Paclitaxel-Eluting Nitinol Stents (Zilver PTX) in the Treatment of Superficial Femoral Artery (SFA) lesions at 12 and 24 Months

Trial Profile

A Single-Arm Study Assessing the Safety and Efficacy of Paclitaxel-Eluting Nitinol Stents (Zilver PTX) in the Treatment of Superficial Femoral Artery (SFA) lesions at 12 and 24 Months

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial occlusive disorders; Peripheral artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top